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INTRODUCTION
Hyponatremia and an increased production of urine are fre-
quently observed after calvarial remodeling in patients with
craniosynostosis. Hypoosmotic conditions result due to sodi-
um loss in the body when these symptoms are not corrected
appropriately, leading to dysfunctional cerebral blood flow,
circulation problems, cerebral edema, or increased intracranial
pressure. Peters et al. (1) described hyponatremia associated
with cerebral disease for the first time in 1950. Initially, the
loss of central nervous system control on renal sodium regu-
lation was thought to be the cause so that hyponatremia was
termed cerebral salt wasting (CSW). In 1957, however, Sch-
warz et al. (2) reported the syndrome of inappropriate anti-
diuretic hormone (SIADH) secretion as hyponatremia after
brain disease or brain surgery, and the clinical entity of CSW
was viewed as either an extremely rare disorder or a misnomer
for what was truly SIADH. Only in recent years has CSW
been thought of as a distinct entity, and this recognition has
been particularly striking in the field of neurosurgery, where
it is viewed as a more common disorder than SIADH (3-5).
The clinical findings are more consistent with CSW than
SIADH as the cause of postoperative and postinjury fluid and
electrolyte changes. Berger et al. showed that the release of
one or more natriuretic factors could also play a role in renal
salt wasting seen in CSW, in addition to decreased neural in-
put to the kidney (6). Atrial natriuretic peptide (ANP) and
brain natriuretic peptide (BNP) are important factors in clini-
cally diagnosing CSW. 
CSW and SIADH are two conditions that show hypona-
tremia after central nervous system (CNS) injury. The causes
and treatment principles of the two conditions are totally dif-
ferent, and thus the differential diagnosis is critical. Many
authors reported the disorder of salt and water homeostasis
in patients with brain lesions such as traumatic brain injury,
subarachnoid hemorrhage, and brain tumor. However, not
much data are available on transient hyponatremia and an in-
creased urinary output after calvarial remodeling (7).
In this study, we evaluated pediatric patients with hypona-
tremia developing after calvarial remodeling due to premature
fusion of cranial sutures to investigate the method of early
differential diagnosis between CSWS and SIADH and appro-
priate treatment methods.
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Cerebral Salt Wasting Syndrome After Calvarial Remodeling in
Craniosynostosis 
Hyponatremia and increased urine output after calvarial remodeling have been noted
in pediatric patients with craniosynostosis. If not treated properly, patients develop
hypoosmotic conditions that can lead to cerebral edema, increased intracranial pres-
sure, and collapsed circulation. Postoperative hyponatremia after central nervous
system surgery is considered as the syndrome of inappropriate antidiuretic hormone
(SIADH) secretion. Recently, however, cerebral salt wasting syndrome (CSWS) in-
stead of SIADH has been reported frequently. CSWS is associated with a decreased
serum sodium level, increased urinary sodium level, increased urine output, decreas-
ed ECF volume, increased atrial natriuretic peptide (ANP) level, and increased brain
natriuretic peptide (BNP) level. We experienced nine patients with craniosynostosis
who underwent calvarial remodeling. By postoperative day 1, the ANP and BNP lev-
els increased by 3-6 folds compared with the preoperative levels. They returned to
the normal levels by postoperative day 5. The ADH level was within the normal range
even after operation. The urinary sodium level increased in all patients by postopera-
tive day 1 and 3. But the serum sodium level, and serum and urine osmolarity were
normal due to appropriate replacement of sodium and fluid. After calvarial remodel-
ing, the potential development of CSWS should be considered and distinguished
from SIADH. The patients with CSWS require normal saline resuscitation and
should prophylactically receive normal saline.
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MATERIALS AND METHODS
Calvarial remodeling was performed in 9 patients with
craniosynostosis from February 2002 to October 2004 in the
department of plastic surgery at St. Mary’s Hospital. The aver-
age age of the patients was 34 months, with a range from 14
months to 6 yr. Total calvarial remodeling was performed in
2 patients with sagittal synostosis. Anterior 2/3 calvarial re-
modeling was performed in 5 cases of metopic synostosis, 1
case of bicoronal synostosis, and 1 case of frontonasal dyspla-
sia. Although postoperative fluid therapy, intensive care unit
stay, and total hospital stay were slightly different the basic
method of surgery and treatment protocol after surgery were
the same in all patients. 
Central vein catheter was inserted in all patients. Immedi-
ately after surgery in intensive care unit, vital signs, urinary
output per hour, oral intake, and fluid intake were measured.
Urinary sodium concentration, urine osmolarity, urine specific
gravity, RBC, WBC, prothrombin time (PT), activated par-
tial thrombin time (aPTT), BUN, levels of creatine, albumin,
serum sodium and potassium, weight change, and chest ra-
diography were checked every day. The levels of antidiuretic
hormone, ANP, and BNP were monitored by postoperative
days 1, 3, and 5. After surgery 0.9% normal saline was admin-
istered in 9 patients under the strict monitoring of the volume
of saline input and amount of urine output.
RESULTS 
No remarkable event occurred after calvarial remodeling in
all of 9 patients. The major parameters measured are shown
in Table 1. Although transient hyponatremia was seen during
the postoperative period, the serum sodium concentrations
(139-141 mEq/L) were within the normal range (135-148
mEq/L) after postoperative day 1 due to normal saline resursci-
tation that had started immediately after surgery. Urine out-
put was increased in all patients between postoperative 1 and
2 days (>1 mL/kg/hr). Urinary sodium concentration was in-
creased significantly by postoperative 1 and 3 days at 164.89
1 M/4 yr Metopic 137 137 138 152 142 81 92 10 36 163 2 6.4 2.3 2.7 1.4
2 M/14 M Metopic 142 140 148 23 29 48 140 58 67 209 42.5 2 4.4 3.9 1.9
3 M/13 M Sagittal 136 144 143 188 74 28 120 90 12 270 31 9.1 2.6 3.5 3.9
4 M/6 yr Sagittal 138 135 146 162 122 35 110 110 39 123 38 8 2.3 3.4 1.5
5 M/18 M Metopic 142 139 144 145 188 28 89 65 25 201 13.8 8.4 1.3 3.7 4.4
6 M/12 M Metopic 138 141 134 130 183 26 12 50 10 17.1 61.2 2.1 8 4.2 5.5
7
M/5 yr Frontonasal  136 144 143 250 210 127 170 230 10 38.8 72.3 2 5.1 2.9 3.9
dysplasia
8 F/11 M Bicoronal 142 137 140 193 53 35 90 70 32 170 29 2.7 2.9 3.3 1.8
9 M/5 yr Metopic 141 134 135 241 150 71 150 100 35 155 41 4.5 3.1 3.7 2.1
ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; ADH, antidiuretic hormone.
Fig. 1. Changes of electrolyte values and osmolarity in the patients
at preoperative and postoperative 1st-5th day. PNa+, Plasma level
of Na+; UNa+, Urine level of Na+; Posm, Plasma osmolarity; Uosm,
Urine osmolarity.
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Fig. 2. Changes of atrial natriuretic peptides (ANP), brain natriuretic
peptide (BNP) and antidiuretic hormones (ADH) in the patients at
preoperative and postoperative 1st through 5th day.
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Table 1. Clinical characteristics and outcomes
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Cranio-
synostosis
Urine Na+ Level
(mEq/L)
5 day 3 day 1 day
ADH (pg/mL)
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5 day 3 day 1 day
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±67.34 mEq/L and 127.89±36.65 mEq/L, respectively,
showing a two-fold increase compared with 60±52.59 mEq/
L measured before the procedure (p<0.05). It returned to the
preoperative level by postoperative day 5 at 53.22±33.98
mEq/L. No significant changes were observed in serum and
urine osmolarity during the 5 days after surgery (Fig. 1).
The ANP level was increased significantly by postopera-
tive days 1 and 3 at 108.11±46.01 pg/mL and 87±61.31
pg/mL, respectively (p<0.05). But it fell into the normal range
(25-77 pg/mL) by postoperative day 5 at 29.56±18.24 pg/
mL, recovering to the preoperative level at 29.57±21.32 pg/
mL. The BNP level was also increased dramatically by post-
operative day 1 at 149.66±80.49 pg/mL, but decreased to
36.76±21.63 pg/mL by postoperative day 3 and dropped
further to 5.02±2.98 pg/mL by postoperative day 5. These
figures all showed statistically significant differences (p<0.05).
The level of antidiuretic hormone was normal in all patients
(0.0-6.7 pg/mL) and showed no statistical significance (Fig. 2).
The length of stay at intensive care unit stay was 4-6 days.
Calvarial remodeling was successful without apparent prob-
lems in all 9 patients, who recovered and discharged without
serious complications. 
DISCUSSION 
Hyponatremia is frequently encountered in pediatric pa-
tients after calvarial remodeling surgery due to premature
fusion of sutures. When this condition is not corrected in a
timely manner, it leads to cerebral edema and an increased
intracranial pressure as blood flow to CNS is decreased due
to low osmolarity. In 1950 Peter et al. (1) coined the term
cerebral salt wasting syndrome (CSWS) to describe a decreased
volume of extracellular fluid resulting from a decreased serum
sodium concentration in not only patients who underwent
calvarial remodeling but also those with traumatic CNS injury
and those with CNS lesions such as cerebral hemorrhage and
brain lesion. It was misunderstood as hyponatremia due to
the SIADH reported by Schwarz et al. in 1957 (2). Recently,
however, many authors reported that these two metabolic
changes are completely different entities having different me-
chanisms and treatment approaches (3-5). 
SIADH is a condition where an increased ECF volume re-
sults from an excess production of ADH, which promotes re-
nal water reabsorption. Thus, urine output decreases and urine
osmolarity increases since water reabsorption is increased. As
a result, weight gain and edema or engorged neck veins are
observed, and hyponatremia is also seen due to the effect of
dilution (2). However, most cases of SIADH do not typically
show edema or engorged neck veins because only 1/3 of total
body fluid is extracellular fluid. SIADH results in an increased
intravascular volume so that it brings about not only increased
renal flow and glomerular filtration rate but also decreased
proximal sodium reabsorption and urinary sodium excretion
(8). The gold standard protocol for treating SIADH, which
show increased body fluid, decreased BUN/creatine ratio, and
lower osmolarity, is to restrict water intake.
On the other hand, CSWS is defined as a condition present-
ed with hyponatremia and decreased extracellular fluid vol-
ume due to renal loss of sodium in the presence of a disorder
of CNS (5) Although the mechanism of CSWS development
is poorly understood, the possible mechanisms involve the
disruption of neural input into the kidney and/or central elab-
oration of circulating natriuretic factors. Decreased sympathet-
ic input by disruption of neural input to the kidney could be
an explanation for impaired proximal reabsorption because
the sympathetic nervous system (SNS) has been shown to alter
salt and water handling in the kidney (4). The release of one
or more natriuretic factors such as ANP and BNP increases
urinary sodium excretion without causing hypokalemia, and
ANP and BNP can also directly decrease the autonomic out-
flow through effects at the brain stem level (6, 8). Either or
both of these mechanisms increase urinary sodium excretion,
eventually decreasing the effective arterial blood volume and
inducing CSWS (8). Berger et al. thought that ADH, ANP,
and BNP are the common controlling factors of SIADH and
CSWS, which maintain the equilibrium in most cases. How-
ever, hyponatremia is induced when these controlling factors
lose the equilibrium in pathologic states (6). In SIADH, the
ADH secretion is increased, whereas the plasma concentra-
tions of ANP and BNP are normal. However, a normal plas-
ma ADH concentration, markedly increased plasma level of
natriuretic peptides, and particularly BNP are observed in
CSWS. The patients in this study showed significantly in-
creased levels of ANP and BNP after surgery, with BNP sho-
wing a larger increase. On the other hand, ADH showed no
significant change after surgery.
The major features of CSWS include a decreased plasma
sodium concentration, increased urinary sodium concentra-
tion, increased urine output, decreased extracellular fluid, in-
creased levels of ANP and BNP, and increased osmolarity;
thus, volume-for-volume fluid and sodium replacement is
essential for the treatment of CSWS (4). Our patients also
showed these features, confirming the diagnosis of CSWS. 
The appropriate treatment for CSWS is maintaining the
body fluid volume and balancing the electrolyte concentra-
tions. When CSWS is misdiagnosed as SIADH and treated
with fluid restriction, which is the initial method of treatment
for SIADH, decreased cerebral perfusion is induced with the
development of hemoconcentration, vasospasm and hypoten-
sion. Furthermore, if postoperative hyponatremia is not cor-
rected early, it may induce decreased CNS blood flow, cerebral
edema, and increased intracranial pressure due to low osmo-
larity (3). Oral intake of sodium drink is ideal but fluid thera-
py is needed when oral intake is not possible. When the wa-
ter and sodium are supplied through intravenous injection,
0.9% normal saline solution or 3% salt solution is the choice.
Here, the correction of hyponatremia needs to be done to thePostoperative Metabolic Change after Calvarial Remodeling  869
levels to prevent the occurrence of central pontine myelinol-
ysis. In addition, the rate of injection of saline solution should
be at 1-2 mM/L per hour and should be monitored not to ex-
ceed 25 mEq/L per day. Occasionally, an injection of a normal
saline solution with blood diuretics such as furosemide is con-
sidered (9). The use of corticosteroids (such as Fludrocortisone
�) is also possible. Corticosteroids directly act on the distal
tubule of the kidney, thereby directly increasing the sodium
absorption and improving hyponatremia. However, the use
of these drugs should be considered carefully since fatal side
effects such as hypertension, hypocalcemia, and pulmonary
edema could develop (10). 
Many authors reported that CSWS developed in patients
with brain lesions such as craniocerebral injuries, subarach-
noid hemorrhage, and brain tumor and patients who under
went neurosurgery (3-5). However, Levin et al. reported that
it is also related with pediatric patients who underwent cal-
varial remodeling (7). These pediatric patients showed hypo-
natremia despite appropriate normal saline injection after
surgery, natriuresis and increased level of ANP. They stated
that the injection of usual pediatric fluid, i.e., 0.25% normal
saline, worsened hyponatremia. The pediatric patients in this
study showed similar findings after calvarial remodeling as
those in the study by Levin et al. (7) and Lee et al. (11), but
we could maintain the optimal sodium levels through strict
monitoring and resuscitation. Thus, CSWS develops easily
in not only patients with brain lesions such as craniocerebral
injuries, subarachnoid hemorrhage, and brain tumor and pa-
tients who underwent neurosurgery but also pediatric patients
who have underwent calvarial remodeling so that complica-
tions should be minimized through appropriate early inter-
vention.
In conclusion, the possibility of CSWS should be considered
initially in the patients who develop hyponatremia after cal-
varial remodeling due to craniosynostosis. Although the exact
mechanism of the development of CSWS has not been eluci-
dated, the disruption of neural input into the kidney and/ or
central elaboration of circulating natriuretic factors are consid-
ered to be the possible mechanisms. Unlike SIADH requiring
fluid restriction, CSWS requires fluid and sodium replace-
ment; thus, differential diagnosis between these two condi-
tions is critical, and the serum ADH, ANP, and BNP levels
and urinary sodium level are very important for the differen-
tial diagnosis.
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